Navigation Links
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Date:9/27/2007

CLARITY and COMMIT trials."

The 300mg tablet is bioequivalent to four 75mg FDA approved tablets of PLAVIX. The 300mg tablet of clopidogrel will be available in the U.S. later this year and is also currently under European Medicines Evaluation Agency (EMEA) review.

About PLAVIX

PLAVIX is a prescription antiplatelet medicine taken once a day that helps keep platelets in the blood from sticking together and forming clots. Since its initial approval on November 17, 1997, by the U.S. Food and Drug Administration, PLAVIX has been prescribed to more than 52 million patients worldwide. The new 300mg loading dose tablet reinforces the strong commitment of two research and development pharmaceutical companies dedicated to improving patient health.

The efficacy and safety of PLAVIX have been established through four landmark clinical trials involving more than 81,000 patients. Plavix is the only widely available prescription antiplatelet that provides proven protection against a future heart attack or stroke for patients with ACS (UA, NSTEMI, STEMI) and recent MI, recent Stroke, or established peripheral artery disease.

PLAVIX has demonstrated early and long-term risk reduction for patients at risk for atherothrombotic events in important clinical trials. In the CURE trial, patients with unstable angina (UA) and non-ST segment elevation myocardial infarction (NSTEMI) receiving PLAVIX with aspirin were followed for up to one year, and in the CAPRIE trial, patients with recent MI, recent ischemic stroke, or established peripheral artery disease receiving PLAVIX alone were followed for up to three years.

PLAVIX is marketed worldwide by sanofi-aventis (Paris Bourse: EURONEXT: SAN; New York: NYSE: SNY) and Bristol-Myers Squibb Company (NYSE:

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Integration of the LEADseeker Multimodality Imaging System with automated plate loading and incubation using Overlord Instrument software
9. Marquette targets illegal downloading
10. Though VC investing is down, reloading on new funds is rising
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... 24 /- Abaxis, Inc.,(Nasdaq...g point-of-care,blood analysis systems, today repo...r ended June 30, 2008., Quarterly highlights in...ast year,s comparable quarter. -- Total sales of ...p 127 units or 19% over last year,s comparable...
(Date:7/24/2008)...logy Veteran to Help Spearhead Growth, PITTSBURGH...s (HMS), (http://www.hmsinc.com ), pioneering heal...S. Dockrell has been appointed vice president, sal...ence in sales, sales,management and product distri...al device and pharmaceutical companies., "Karen h...
(Date:7/24/2008)... /- The Global Probiotics Council,(GP...NE and Yakult Honsha,Co., Ltd., announced the two ...stigator Grant for Probiotics Research (YIGPRO) to...ing stars who will continue to contribute to,the a...ch in the United,States., Ajay S. Gulati, MD, an ...
(Date:7/24/2008)...ternative will be Centerpiece to Expansion of ...NYVALE, Calif., July 24 /- ...ader in the field of radiosurgery,today announced... purchased,a CyberKnife(R) Robotic Radiosurgery Sy... nationally recognized NeuroScience Center program...
Breaking Biology Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 8Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 2St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 3St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 4
...tics Corp. , a custom injection molder and materia...tered into a collaborative agreement with a St. Pa... stem cell therapeutics for orthopedic application...s human stem cells for drug discovery and therapeu...technologies in the form of bio-devices, and has e...
...ists who heretofore have not had to worry much abo...ay soon be asked to add another dimension to their...resence in the global market. , ,With Wisconsin i...nual pace - up 15.1 percent to $17.2 billion in 20...oreign markets, more technologists will be relied ...
...en-owned businesses to the $1 million annual reven...ols, perhaps none more important than information ...e out of the recent Wisconsin Make Mine a Million...raged to leverage information technology to a grea...mark. , ,The advice they absorbed from the likes o...
...ynch, a partner with the law firm Michael Best & ...a Riske, the firm,s director of government affairs...artment of Energy has announced $200 million in n...his funding opportunity is open to applicants with...h and development to design, construction, and ope...
Other Biology Technology:Phillips Plastics to help develop orthopedics with stem cells 2Phillips Plastics to help develop orthopedics with stem cells 3Visions: IT exec says CIOs must be ready to help companies ramp up trade 2Visions: IT exec says CIOs must be ready to help companies ramp up trade 3Visions: IT exec says CIOs must be ready to help companies ramp up trade 4Learning from the big boys: With technology, women urged to go gradual 2Learning from the big boys: With technology, women urged to go gradual 3Wisconsin applicants urged to pursue DOE funding for cellulosic biomass 2
(Date:7/25/2008)...niversity of Houston department of health and huma...of Second Life (SL) thanks to grants from the UH F...he Network Culture Project of the University of So...on. , "These funds will allow our faculty to sta...udents and our community," said Charles Layne, pro...
(Date:7/25/2008)...ALO, N.Y. -- Children born with hydrocephalus, or ... drain the fluid away from the brain to reduce har..., the rate of shunt infection in children is very ...ing the child through another surgery to replace t...ential additional neurological complications and a...
(Date:7/24/2008)...cal food shortages and growing demand for bio-fuel...ices rank among the greatest threats today to the ...mers and developers look for new areas for agricul...However, resisting pressures to convert wetlands i...e a suite of services essential to humanity, inclu...
(Date:7/24/2008)...es embedded with a telescope promise to make it ea...do other activities requiring sharper distance vis...scribe the advantages of these innovative glasses ...e May/June issue of Journal of Biomedical Optics ... , "This new design has several advantages," sa...
Breaking Biology News(10 mins):Second Life a first for UH department of health and human performance 2Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 3Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Mindray Medical International Announces First Quarter 2008 Results 5203 1Mindray Medical International Announces First Quarter 2008 Results 5203 2Mindray Medical International Announces First Quarter 2008 Results 5203 3Mindray Medical International Announces First Quarter 2008 Results 5203 4Mindray Medical International Announces First Quarter 2008 Results 5203 5Mindray Medical International Announces First Quarter 2008 Results 5203 6Mindray Medical International Announces First Quarter 2008 Results 5203 7Mindray Medical International Announces First Quarter 2008 Results 5203 8Mindray Medical International Announces First Quarter 2008 Results 5203 9Mindray Medical International Announces First Quarter 2008 Results 5203 10Mindray Medical International Announces First Quarter 2008 Results 5203 11Mindray Medical International Announces First Quarter 2008 Results 5203 12Mindray Medical International Announces First Quarter 2008 Results 5203 13Mindray Medical International Announces First Quarter 2008 Results 5203 14Mindray Medical International Announces First Quarter 2008 Results 5203 15Mindray Medical International Announces First Quarter 2008 Results 5203 16Mindray Medical International Announces First Quarter 2008 Results 5203 17Mindray Medical International Announces First Quarter 2008 Results 5203 18FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 2FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 3James T Glover Appointed to Board of Directors of Varian Inc 5197 1James T Glover Appointed to Board of Directors of Varian Inc 5197 2MIT study suggests caution on new anti obesity drug in kids 18717 1MIT study suggests caution on new anti obesity drug in kids 18717 2
...ynesthesia in which they see colors when viewing l...rs, led by Edward M. Hubbard of the University of ...ctional magnetic resonance imaging (fMRI) of their...-perception areas. , The researchers said their fi...dition is due to cross-activation between adjacent...
... Center at Dallas,researchers have found a way of ...ainst amyloid proteins that cause the devastating ...ease.,For years scientists have examined the possi...e progression of the disease in its,early stages. ...sed,vaccine aimed at stimulating the immune system...
...0 years ago, as the last ice age was beginning to ...est Antarctica. , But in a new study led by Unive...000 meters was used as a sort of dipstick to show ... probably never contained as much ice as scientist...t have contributed as much to the higher sea level...
...or ,hair cells,responsible for hearing and balanc...s known as glia may be essential for the normal de...nd balance, according to new,University of Utah re...05 issue of Neuron and is co-authored by scientist...h as a model, we,ve demonstrated that glial cells ...
Other Biology News:New insight into people who 'see' colors in letters and numbers 2Gene vaccine for Alzheimer's disease shows promising results 2Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 2Ice core 'dipstick' indicates West Antarctic ice has thinned less than believed 3Zebrafish may hold key to understanding human nerve cell development 2
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry.
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry.
Request Info
Flammable Chemical Cabinets, Justrite Model 25042 from South Coast Enterprises
Biology Products: